Schmidt, Reinhold

Plasma Antioxidants and Cognitive Performance in Middle‐Aged and Older Adults: Results of the Austrian Stroke Prevention Study

Schmidt, R., Hayn, M., Reinhart, B., Roob, G., Schmidt, H., Schumacher, M., Watzinger, N., & Launer, L. J. (1998) · Journal of the American Geriatrics Society

Dementia and Cognitive Impairment ResearchAntioxidant Activity and Oxidative Stress

Cited by 96

Association of common genetic variants with brain microbleeds: a genome-wide association study

Knol, M. J., Lu, D., Traylor, M., Adams, H. H. H., Romero, J. R. J., Smith, A. V., Fornage, M., Hofer, E., Liu, J., Hostettler, I. C., et al. (2020) · Neurology

Intracerebral and Subarachnoid Hemorrhage ResearchCerebrovascular and genetic disorders

Cited by 94

The association between lower educational attainment and depression owing to shared genetic effects? Results in ~25 000 subjects

Peyrot, W. J., Lee, S. H., Milaneschi, Y., Abdellaoui, A., Byrne, E. M., Esko, T., de Geus, E. J. C., Hemani, G., Hottenga, J. J., Kloiber, S., et al. (2015) · Molecular Psychiatry

Genetic Associations and EpidemiologyNeurotransmitter Receptor Influence on Behavior

Cited by 84

The association of the 4q25 susceptibility variant for atrial fibrillation with stroke is limited to stroke of cardioembolic etiology

Lemmens, R., Buysschaert, I., Geelen, V., Fernandez-Cadenas, I., Montaner, J., Schmidt, H., Schmidt, R., Attia, J., Maguire, J., Levi, C., et al. (2010) · Stroke

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 77

Low-dose ladostigil for mild cognitive impairment: A phase 2 placebo-controlled clinical trial

Schneider, L. S., Geffen, Y., Rabinowitz, J., Thomas, R. G., Schmidt, R., Ropele, S., Weinstock, M., & on behalf of the Ladostigil Study Group (2019) · Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 75

Temporal changes in total and hippocampal brain volume and cognitive function in patients with chronic heart failure—the COGNITION. MATTERS-HF cohort study

Frey, A., Homola, G. A., Henneges, C., Mühlbauer, L., Sell, R., Kraft, P., Franke, M., Morbach, C., Vogt, M., Müllges, W., et al. (2021) · European Heart Journal

Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and Treatments

Cited by 70

Diffusion changes predict cognitive and functional outcome: The LADIS study

Jokinen, H., Schmidt, R., Ropele, S., Fazekas, F., Gouw, A. A., Barkhof, F., Scheltens, P., Madureira, S., Verdelho, A., Ferro, J. M., et al. (2013) · Annals of Neurology

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 68

A priori collaboration in population imaging: The Uniform Neuro‐Imaging of Virchow‐Robin Spaces Enlargement consortium

Adams, H. H. H., Hilal, S., Schwingenschuh, P., Wittfeld, K., van der Lee, S. J., DeCarli, C., Vernooij, M. W., Katschnig‐Winter, P., Habes, M., Chen, C., et al. (2015) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Cerebrospinal fluid and hydrocephalusAdvanced MRI Techniques and Applications

Cited by 59

Genome-wide association study of 23,500 individuals identifies 7 loci associated with brain ventricular volume

Vojinovic, D., Adams, H. H., Jian, X., Yang, Q., Smith, A. V., Bis, J. C., Teumer, A., Scholz, M., Armstrong, N. J., Hofer, E., et al. (2018) · Nature Communications

Genetic Associations and EpidemiologyCerebrospinal fluid and hydrocephalus

Cited by 52

Amyloid pathology and vascular risk are associated with distinct patterns of cerebral white matter hyperintensities: A multicenter study in 3132 memory clinic patients

Biesbroek, J. M., Coenen, M., DeCarli, C., Fletcher, E. M., Maillard, P. M., Initiative, A. D. N., Barkhof, F., Barnes, J., Benke, T., Chen, C. P. L. H., et al. (2024) · Alzheimer's & Dementia

Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research

Cited by 38

Genetics of subcortical vascular dementia

Schmidt, H., Freudenberger, P., Seiler, S., & Schmidt, R. (2012) · Experimental Gerontology

Cerebrovascular and genetic disordersNeurological Disease Mechanisms and Treatments

Cited by 37

Meta-analysis of genetic association with diagnosed Alzheimer’s disease identifies novel risk loci and implicates Abeta, Tau, immunity and lipid processing

Kunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory)

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 35

Different types of white matter hyperintensities in CADASIL

Duchesnay, E., Hadj Selem, F., De Guio, F., Dubois, M., Mangin, J.-F., Duering, M., Ropele, S., Schmidt, R., Dichgans, M., Chabriat, H., et al. (2018) · Frontiers in Neurology

Cerebrovascular and genetic disordersIntracerebral and Subarachnoid Hemorrhage Research

Cited by 31

Prediction of 3-year clinical course in CADASIL

Jouvent, E., Duchesnay, E., Hadj-Selem, F., De Guio, F., Mangin, J.-F., Hervé, D., Duering, M., Ropele, S., Schmidt, R., Dichgans, M., et al. (2016) · Neurology

Cerebrovascular and genetic disordersIntracerebral and Subarachnoid Hemorrhage Research

Cited by 30

Effects of Psychotropic Medication on Cognition, Caregiver Burden, and Neuropsychiatric Symptoms in Alzheimer’s Disease over 12 Months: Results from a Prospective Registry of Dementia in Austria (PRODEM)

Pirker-Kees, A., Dal-Bianco, P., & Schmidt, R. (2019) · Journal of Alzheimer s Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 17

Amyloid-beta antibody treatment in Alzheimer’s disease: An update on recent data and outlook on implementation in clinical routine

Stögmann, E., & Schmidt, R. (2025) · Wiener klinische Wochenschrift

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 6